MediWound Ltd (NASDAQ: MDWD) stock enjoyed a major increase of 35.1% on 7/5/24. The shares closed at $19.60. Moreover, trading volume in this advance was exceptionally high at 2364% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 28.8% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, MDWD is expected to be Value Creation neutral.
MediWound has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. MediWound has a very low Appreciation Score of 4 but a very high Power Rating of 89, with the Low Neutral Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment